AIDS

1. MOUSSAOU ME, Ladang A, Maes N, Cavalie E, et al
   Heterogeneity of baseline immune activation and SARS-CoV-2 vaccine responses in people with HIV: a multicenter prospective study.
   AIDS. 2026 Jun 2. doi: 10.1097/QAD.0000000000004557.
   

   >> Share

   
   

   
   Ann Intern Med

2. CENTOR RM, Lee RA
   Annals On Call - Who Should Receive the RSV Vaccine?
   Ann Intern Med. 2026 Jun 2:e2602379OC. doi: 10.7326/ANNALS-26-02379.
   

   >> Share

   
   

   
   BMJ

3. BARANIUK C
   Ebola: Three vaccines rushed into development for Bundibugyo outbreak.
   BMJ. 2026;393:e557985.
   

   >> Share

   
   
4. WILLIAMS S
   Six ways Gavi will continue to immunise half the world's children amid vaccine backlash and a funding crisis.
   BMJ. 2026;393:e393658.
   

   >> Share

   
   

   
   Clin Infect Dis

5. BONTEN M, Essink B, Hanning N, Leroux-Roels I, et al
   Immunogenicity and safety of co-administration of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine and a COVID-19 mRNA vaccine in adults aged >/=50 years: a phase 3, randomized, non-inferiority trial.
   Clin Infect Dis. 2026 Jun 4:ciag344. doi: 10.1093.
   

   >> Share

   
   
6. LIU C, Okoli GN, Chen R, Sullivan SG, et al
   SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis.
   Clin Infect Dis. 2026 Jun 1:ciag346. doi: 10.1093.
   

   >> Share

   
   

   
   J Infect Dis

7. FREYN AW, Budigi Y, Girard B, Santos G, et al
   Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
   J Infect Dis. 2026 Jun 4:jiag248. doi: 10.1093.
   

   >> Share

   
   
8. CARDUCCI M, Sarakinou E, Massai L, Rovetini L, et al
   Immunogenicity of a Bivalent Typhoid-Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A Isolates.
   J Infect Dis. 2026 Jun 3:jiag275. doi: 10.1093.
   

   >> Share

   
   
9. GODDARD K, Ellingson MK, Brewer NT
   How to Fight for Immunization When Vaccine Skeptics Are Calling the Shots.
   J Infect Dis. 2026 Jun 3:jiag252. doi: 10.1093.
   

   >> Share

   
   
10. FREEDMAN DO
    Chikungunya Vaccines for Travelers: Unanswered Pragmatic Questions Persist.
    J Infect Dis. 2026 May 30:jiag284. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

11. WANG L, Shen J
    Progress in enterovirus D68-neutralizing antibodies and vaccines.
    J Virol. 2026 Jun 3:e0012326. doi: 10.1128/jvi.00123.
    

    >> Share

    
    

    
    JAMA

12. JENG WJ, Yip TC, Lok AS
    Hepatitis B: A Review.
    JAMA. 2026 May 4. doi: 10.1001/jama.2026.6070.
    

    >> Share

    
    

    
    Nat Immunol

13. KELCHTERMANS L, Geerts K, Pham CT, Malviya V, et al
    CD4(+) T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection.
    Nat Immunol. 2026;27:1224-1236.
    

    >> Share

    
    
14. SARAIVA M, Branchett WJ, Rengarajan J, O'Garra A, et al
    The host immune response to Mycobacterium tuberculosis determining protection or disease progression.
    Nat Immunol. 2026;27:1104-1118.
    

    >> Share

    
    

    
    Nat Med

15. DE JONG SPJ, Russell CA
    Limited evidence of AI superiority in seasonal influenza vaccine strain selection.
    Nat Med. 2026 Jun 3. doi: 10.1038/s41591-026-04461.
    

    >> Share

    
    
16. SHI W, Wohlwend J, Wu M, Barzilay R, et al
    Reply to: Limited evidence of AI superiority in seasonal influenza vaccine strain selection.
    Nat Med. 2026 Jun 3. doi: 10.1038/s41591-026-04460.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

17. KRIEG V, Nickson N, Eberly MD, Manaloor J, et al
    A Case Series of Vaccine-strain Reactivation Varicella Zoster in Two Pediatric Patients Presenting With Headache and Rash.
    Pediatr Infect Dis J. 2026 Jun 3. doi: 10.1097/INF.0000000000005300.
    

    >> Share

    
    

    
    PLoS One

18. ODEBUNMI OO, Ilyasova A, Bamogo A, Patel Y, et al
    Exploring primary care health professionals' perceived influence of their communication on HPV vaccine acceptance: Results from a national survey.
    PLoS One. 2026;21:e0350507.
    

    >> Share

    
    
19. AKELLO LM, Osuret J, Galiwango J, Mwaka AD, et al
    Hepatitis B vaccine uptake and associated factors among pregnant women attending antenatal care at Gulu Regional Referral Hospital, Northern Uganda.
    PLoS One. 2026;21:e0350568.
    

    >> Share

    
    
20. ANACONA GPV, Correa ACG, Narvaez-Cuenca CE, Vasquez TM, et al
    Exploring the genetic architecture underlying dietary fiber content in Colombian Andean blueberry (Vaccinium meridionale Swartz).
    PLoS One. 2026;21:e0344321.
    

    >> Share

    
    

    
    Vaccine

21. NOUHI A, Abolmaali S, Darvish Alipour Astaneh S
    XcpQ from Pseudomonas aeruginosa: A potential vaccine candidate with immunogenic properties in zebrafish.
    Vaccine. 2026;87:128768.
    

    >> Share

    
    
22. SHARMA A, Kerkhoff AD, Haambokoma M, Shamoya B, et al
    Corrigendum to "Intention to receive new vaccines post-COVID-19 pandemic among adults and health workers in Lusaka, Zambia" ["Vaccine 50 (2025) 126846].
    Vaccine. 2026 May 31:128757. doi: 10.1016/j.vaccine.2026.128757.
    

    >> Share

    
    
23. DAS S, Tenaglia BM, Riley D, Speed S, et al
    BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy.
    Vaccine. 2026;87:128774.
    

    >> Share

    
    
24. VOLPI CR, Chama J, Adebiyi R, Aigoro JA, et al
    Understanding HPV vaccine preferences among sexual minority men living with HIV in Abuja, Nigeria using a discrete choice experiment.
    Vaccine. 2026;87:128771.
    

    >> Share

    
    
25. LI Y, Dong X, Yang A, Yu X, et al
    Development and efficacy evaluation of an inactivated Bordetella bronchiseptica vaccine in cats.
    Vaccine. 2026;87:128778.
    

    >> Share

    
    
26. EIDEN AL, Zheng Y, Wang D, Frew PM, et al
    Changes in attitudes and beliefs about childhood vaccination among parents in the United States: A repeat cross-sectional survey before and after the COVID-19 pandemic.
    Vaccine. 2026;87:128760.
    

    >> Share

    
    
27. DIVANI M, Katsanaki A, Poulianiti C, Lykotsetas E, et al
    Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients.
    Vaccine. 2026;87:128776.
    

    >> Share

    
    
28. DELLA CIOPPA G, Sahai N, Dodeur V, Dutton JL, et al
    Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo-
    Vaccine. 2026;87:128772.
    

    >> Share

    
    
29. LE TOURNEAU N, Sharma A, Pry JM, Haambokoma M, et al
    Corrigendum to "Drivers of decision-making for future adult vaccines: a best-worst scaling among community members and health care workers in Zambia" [Vaccine 70 (2026) 128003].
    Vaccine. 2026;87:128756.
    

    >> Share

    
    
30. MARIN-CABA E, Lorusso N, Sempere J, Jimenez-Moleon JJ, et al
    Young adults at risk of emerging serotype 4 invasive pneumococcal disease vs. other serotypes in Andalusia (Spain), 2022 to 2024: optimising conjugated vaccines strategies.
    Vaccine. 2026;88:128790.
    

    >> Share

    
    
31. CARAZO S, Skowronski DM, Sauvageau C, Talbot D, et al
    2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.
    Vaccine. 2026;88:128786.
    

    >> Share

    
    
32. MOROS A, Deulofeu M, Ribo M, Bosch-Rue E, et al
    Multiple monovalent COVID-19 PHH-1V vaccine adaptations elicit homologous and cross-neutralizing antibody responses in mice.
    Vaccine. 2026;87:128781.
    

    >> Share

    
    

    
    Virus Res

33. SEDAGHAT M, Najafi F, Khosravi Shademani F, Rezaeian S, et al
    Seasonal influenza vaccine and frequency of adverse events in health workers receiving two doses of AstraZeneca vaccine: a retrospective cohort study.
    Virus Res. 2026;369:199757.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share